Bioactive Scaffold Fabricated by 3D Printing for Enhancing Osteoporotic Bone Regeneration.
Xiaoting ZhangXinluan WangYuk-Wai LeeLu FengBin WangQi PanXiangbo MengHuijuan CaoLinlong LiHaixing WangShanshan BaiLingchi KongDick Ho-Kiu ChowLing QinLiao CuiSien LinGang LiPublished in: Bioengineering (Basel, Switzerland) (2022)
We develop a poly (lactic-co-glycolic acid)/β-calcium phosphate (PLGA/TCP)-based scaffold through a three-dimensional (3D) printing technique incorporating icaritin (ICT), a unique phytomolecule, and secretome derived from human fetal mesenchymal stem cells (HFS), to provide mechanical support and biological cues for stimulating bone defect healing. With the sustained release of ICT and HFS from the composite scaffold, the cell-free scaffold efficiently facilitates the migration of MSCs and promotes bone regeneration at the femoral defect site in the ovariectomy (OVX)-induced osteoporotic rat model. Furthermore, mechanism study results indicate that the combination of ICT and HFS additively activates the Integrin-FAK (focal adhesion kinase)-ERK1/2 (extracellular signal-regulated kinase 1/2)-Runx2 (Runt-related transcription factor 2) axis, which could be linked to the beneficial recruitment of MSCs to the implant and subsequent osteogenesis enhancement. Collectively, the PLGA/TCP/ICT/HFS (P/T/I/S) bioactive scaffold is a promising biomaterial for repairing osteoporotic bone defects, which may have immense implications for their translation to clinical practice.
Keyphrases
- bone regeneration
- tissue engineering
- transcription factor
- mesenchymal stem cells
- cell free
- bone mineral density
- umbilical cord
- clinical practice
- endothelial cells
- signaling pathway
- protein kinase
- cell migration
- tyrosine kinase
- high glucose
- soft tissue
- postmenopausal women
- escherichia coli
- staphylococcus aureus
- bone loss
- cell adhesion
- diabetic rats
- circulating tumor cells